The U.S. plans to provide almost $3 billion in funding to shore up the vaccine supply chain here, federal health officials said Thursday. The investment will go to U.S. companies to build out production lines for supplies like lipids, tubing, needles, syringes, and protective gloves. “This will create thousands of good-paying American jobs, help us deliver on the president’s commitment to be the arsenal of vaccines for the world, and strengthen our long-term capabilities to respond to future threats,” Jeff Zients, the White House’s COVID-19 response coordinator, said during a press briefing.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
